Pain in chemotherapy-induced peripheral neurotoxicity

Area of Science:

• Oncology
• Neuroscience
• Pharmacology

Background:

• Chemotherapy-induced peripheral neurotoxicity (CIPN) is a common, dose-limiting side effect in cancer treatment.
• CIPN primarily affects sensory nerves and is often described as pain.
• The clinical presentation of CIPN varies significantly based on the specific chemotherapy agent used.

Purpose of the Study:

• To highlight the need for a more precise definition of CIPN beyond the general term "pain."
• To emphasize the implications of refined CIPN characterization for clinical trial design.
• To underscore the importance of accurate CIPN phenotyping for selecting effective therapeutic agents.

Main Methods:

• Review of existing literature on chemotherapy-induced peripheral neurotoxicity.
• Analysis of clinical presentations and courses of CIPN associated with different antineoplastic drugs.
• Conceptual framework for refining the definition and classification of CIPN.

Main Results:

• CIPN exhibits diverse clinical features and progression patterns depending on the causative chemotherapy drug.
• A "one-size-fits-all" definition of CIPN as "pain" is insufficient to capture its complexity.
• Specific identification of CIPN symptoms and characteristics is variable.

Conclusions:

• Revisiting and refining the broad term "pain" in the context of CIPN is essential.
• Precise characterization of CIPN is critical for the development of targeted and effective clinical trials.
• Accurate identification of CIPN features will aid in selecting appropriate drugs for managing this side effect.